N~2~-(2,6-dimethyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonyl)-N~2~-methyl-N-[2-(4-methylpiperidin-1-yl)ethyl]glycinamide
Chemical Structure Depiction of
N~2~-(2,6-dimethyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonyl)-N~2~-methyl-N-[2-(4-methylpiperidin-1-yl)ethyl]glycinamide
N~2~-(2,6-dimethyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonyl)-N~2~-methyl-N-[2-(4-methylpiperidin-1-yl)ethyl]glycinamide
Compound characteristics
Compound ID: | G938-1436 |
Compound Name: | N~2~-(2,6-dimethyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonyl)-N~2~-methyl-N-[2-(4-methylpiperidin-1-yl)ethyl]glycinamide |
Molecular Weight: | 452.57 |
Molecular Formula: | C21 H32 N4 O5 S |
Smiles: | CC1CCN(CC1)CCNC(CN(C)S(c1cc2c(cc1C)NC(C(C)O2)=O)(=O)=O)=O |
Stereo: | RACEMIC MIXTURE |
logP: | 1.2338 |
logD: | -0.1452 |
logSw: | -2.3251 |
Hydrogen bond acceptors count: | 11 |
Hydrogen bond donors count: | 2 |
Polar surface area: | 93.707 |
InChI Key: | ASWMCBXYCACHCV-MRXNPFEDSA-N |